[CHRS] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
06-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 28.65%
YoY- -44.88%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 91,524 45,352 73,371 110,419 123,856 0 0 -
PBT -79,653 -58,870 -45,725 10,760 41,271 -62,596 -49,069 8.40%
Tax -10,611 7,377 5,793 1,052 2,044 70 114 -
NP -79,653 -66,247 -45,725 9,708 39,227 -62,596 -49,067 8.40%
Tax Rate - - - -9.78% -4.95% - - -
Total Cost 171,177 111,599 119,096 100,711 84,629 62,596 49,067 23.14%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -87.03 -146.07 -62.32 8.79 31.67 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.71 -0.85 -0.60 0.13 0.56 -0.92 -0.84 -2.76%
EPS Diluted -0.71 -0.85 -0.60 0.12 0.53 -0.92 -0.84 -2.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.